SEC filing – odaterad – 0001104659-26-080617-index.html

Fulltext

EDGAR Filing Documents for 0001104659-26-080617

SEC.gov

EDGAR

Latest Filings

Filings search tools

Filing Detail

SEC Home »

Company Search »

Current Page

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-26-080617

Filing Date

2026-07-06

Accepted

2026-07-06 09:16:51

Documents

2

Period of Report

2026-07-06

Document Format Files

Seq
Description
Document
Type
Size

1
FORM 6-K
tm2619347d1_6k.htm
6-K
10523

2
EXHIBIT 99.1
tm2619347d1_ex99-1.htm
EX-99.1
9616

 
Complete submission text file
0001104659-26-080617.txt
 
21251

Mailing Address
KORNHAMNSTORG 53

STOCKHOLM Sweden
111 27

Business Address
KORNHAMNSTORG 53

STOCKHOLM Sweden
111 27
46(0)317880560

Vicore Pharma Holding AB (Filer)
CIK : 0002124403 (see all company filings)
EIN. : 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-43312 | Film No.: 261154451
SIC : 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)